New Haven’s Arvinas Pioneers Cancer, Disease Treatments
BizCast host Shannon King talks to Arvinas CEO John Houston about their leadership in targeted protein degradation, a new way to treat diseases and cancers.
Houston also discusses why the quality of workforce talent and quality of life in Connecticut have boosted the growth of the bioscience and pharmaceutical industry in the state.
For additional information about the pandemic, including guidance for protecting workplace health and safety, business continuity and planning, risk mitigation, labor and employment law compliance, and more, visit CBIA's coronavirus resource center:
www.cbia.com/resource/category/coronavirus/.
Have a story to tell? Email shannon.king@cbia.com.
